{"entity":{"type":"insider","cik":"0001578976","url":"/insider/0001578976","json_url":"/insider/0001578976.json","name":"Third Rock Ventures GP, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2014-01-14","last":"2018-07-24","span_basis":"filed_date"},"name_variants":[{"name":"Third Rock Ventures GP, L.P.","source":"filing","n_filings":9,"first_seen":"2014-01-14","last_seen":"2018-07-24"}],"transactions":[{"id":6343838,"accession":"0000899243-18-020534","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-020534","line_url":"/filing/0000899243-18-020534#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP, LLC; STARR KEVIN P; THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; LEVIN MARK J","owner_display_name":"TRV GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266667.0,"shares_display":"266,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4000005.0,"total_display":"4,000,005.00","total_whole":"4,000,005","shares_owned_after":2983051.0,"shares_owned_after_display":"2,983,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-24","scope":"insider"},{"id":4212054,"accession":"0000899243-17-008731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-008731","line_url":"/filing/0000899243-17-008731#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP, LLC; LEVIN MARK J; STARR KEVIN P; Third Rock Ventures GP, L.P.; THIRD ROCK VENTURES LP","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650000.0,"shares_display":"650,000","price_per_share":18.0003,"price_display":"18.00","price_state":"stated","total_value":11700195.0,"total_display":"11,700,195.00","total_whole":"11,700,195","shares_owned_after":5170348.0,"shares_owned_after_display":"5,170,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-27","filed_date":"2017-03-27","scope":"insider"},{"id":4212049,"accession":"0000899243-17-008731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-008731","line_url":"/filing/0000899243-17-008731#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"CytomX Therapeutics, Inc.","issuer_ticker":"CTMX","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TEPPER ROBERT I; TRV GP, LLC; LEVIN MARK J; STARR KEVIN P; Third Rock Ventures GP, L.P.; THIRD ROCK VENTURES LP","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":17.0002,"price_display":"17.00","price_state":"stated","total_value":17000200.0,"total_display":"17,000,200.00","total_whole":"17,000,200","shares_owned_after":5820348.0,"shares_owned_after_display":"5,820,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-27","scope":"insider"},{"id":9215335,"accession":"0001012975-15-000294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000294","line_url":"/filing/0001012975-15-000294#line-1","is_derivative":false,"issuer_cik":"0001408591","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001408591","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; TRV GP, LLC; Third Rock Ventures GP, L.P.","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4098778.0,"shares_display":"4,098,778","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":204938900.0,"total_display":"204,938,900.00","total_whole":"204,938,900","shares_owned_after":828456.0,"shares_owned_after_display":"828,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-16","scope":"insider"},{"id":8171539,"accession":"0001012975-15-000282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000282","line_url":"/filing/0001012975-15-000282#line-1","is_derivative":false,"issuer_cik":"0001408591","issuer_name":"Foundation Medicine, Inc.","issuer_ticker":"FMI","issuer_name_source":null,"issuer_url":"/issuer/0001408591","owner_cik":null,"owner_name":"TRV GP, LLC; Third Rock Ventures GP, L.P.; THIRD ROCK VENTURES LP","owner_display_name":"TRV GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3976278.0,"shares_display":"3,976,278","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":198813900.0,"total_display":"198,813,900.00","total_whole":"198,813,900","shares_owned_after":950956.0,"shares_owned_after_display":"950,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-09","scope":"insider"},{"id":6990389,"accession":"0001012975-14-000557","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001012975-14-000557","line_url":"/filing/0001012975-14-000557#line-5","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; TRV GP, LLC","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":36.59,"price_display":"36.59","price_state":"stated","total_value":1390420.0,"total_display":"1,390,420.00","total_whole":"1,390,420","shares_owned_after":1215054.0,"shares_owned_after_display":"1,215,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-12","scope":"insider"},{"id":6990387,"accession":"0001012975-14-000557","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-14-000557","line_url":"/filing/0001012975-14-000557#line-4","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; TRV GP, LLC","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87000.0,"shares_display":"87,000","price_per_share":36.52,"price_display":"36.52","price_state":"stated","total_value":3177240.0,"total_display":"3,177,240.00","total_whole":"3,177,240","shares_owned_after":2329974.0,"shares_owned_after_display":"2,329,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-11","filed_date":"2014-09-12","scope":"insider"},{"id":6275846,"accession":"0001012975-14-000084","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001012975-14-000084","line_url":"/filing/0001012975-14-000084#line-5","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Eleven Biotherapeutics, Inc.","issuer_ticker":"EBIO","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP, L.P.; THIRD ROCK VENTURES LP; TRV GP, LLC; TEPPER ROBERT I; LEVIN MARK J; STARR KEVIN P","owner_display_name":"Third Rock Ventures GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":551482.0,"shares_display":"551,482","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":4841591.0,"shares_owned_after_display":"4,841,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-11","filed_date":"2014-02-13","scope":"insider"},{"id":6459608,"accession":"0001012975-14-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-14-000035","line_url":"/filing/0001012975-14-000035#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; TRV GP, LLC; Third Rock Ventures GP, L.P.","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":23.91,"price_display":"23.91","price_state":"stated","total_value":5977500.0,"total_display":"5,977,500.00","total_whole":"5,977,500","shares_owned_after":2416974.0,"shares_owned_after_display":"2,416,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"},{"id":6855808,"accession":"0001012975-14-000027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000027","line_url":"/filing/0001012975-14-000027#line-3","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; TRV GP, LLC","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":23.96,"price_display":"23.96","price_state":"stated","total_value":335440.0,"total_display":"335,440.00","total_whole":"335,440","shares_owned_after":2666974.0,"shares_owned_after_display":"2,666,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-17","filed_date":"2014-01-17","scope":"insider"},{"id":6855804,"accession":"0001012975-14-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000027","line_url":"/filing/0001012975-14-000027#line-2","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; TRV GP, LLC","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33000.0,"shares_display":"33,000","price_per_share":24.02,"price_display":"24.02","price_state":"stated","total_value":792660.0,"total_display":"792,660.00","total_whole":"792,660","shares_owned_after":2680974.0,"shares_owned_after_display":"2,680,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-17","scope":"insider"},{"id":6855800,"accession":"0001012975-14-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-14-000027","line_url":"/filing/0001012975-14-000027#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.; TRV GP, LLC","owner_display_name":"THIRD ROCK VENTURES LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260000.0,"shares_display":"260,000","price_per_share":22.14,"price_display":"22.14","price_state":"stated","total_value":5756400.0,"total_display":"5,756,400.00","total_whole":"5,756,400","shares_owned_after":2713974.0,"shares_owned_after_display":"2,713,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":6569540,"accession":"0001012975-14-000020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-14-000020","line_url":"/filing/0001012975-14-000020#line-3","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"TRV GP, LLC; THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.","owner_display_name":"TRV GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":270000.0,"shares_display":"270,000","price_per_share":21.91,"price_display":"21.91","price_state":"stated","total_value":5915700.0,"total_display":"5,915,700.00","total_whole":"5,915,700","shares_owned_after":2973974.0,"shares_owned_after_display":"2,973,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-14","filed_date":"2014-01-14","scope":"insider"},{"id":6569537,"accession":"0001012975-14-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000020","line_url":"/filing/0001012975-14-000020#line-2","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"TRV GP, LLC; THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.","owner_display_name":"TRV GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":21.8,"price_display":"21.80","price_state":"stated","total_value":981000.0,"total_display":"981,000.00","total_whole":"981,000","shares_owned_after":3243974.0,"shares_owned_after_display":"3,243,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-14","scope":"insider"},{"id":6569534,"accession":"0001012975-14-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-14-000020","line_url":"/filing/0001012975-14-000020#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":null,"owner_name":"TRV GP, LLC; THIRD ROCK VENTURES LP; Third Rock Ventures GP, L.P.","owner_display_name":"TRV GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":21.98,"price_display":"21.98","price_state":"stated","total_value":549500.0,"total_display":"549,500.00","total_whole":"549,500","shares_owned_after":3288974.0,"shares_owned_after_display":"3,288,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-24","last_seen":"2018-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001501989","name":"CytomX Therapeutics, Inc.","url":"/issuer/0001501989","role":"Ten percent owner","n_filings":1,"first_seen":"2017-03-27","last_seen":"2017-03-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001488613","name":"Foundation Medicine, Inc.","url":"/issuer/0001488613","role":"Ten percent owner","n_filings":2,"first_seen":"2015-04-09","last_seen":"2015-04-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Ten percent owner","n_filings":4,"first_seen":"2014-01-14","last_seen":"2014-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-13","last_seen":"2014-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578976","retrieved_at":"2026-08-22T08:08:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}